Lamivudine And Tenofovir Disoproxil Fumarate Tablets

Get a Price/Quote

Product Details:

Appearance White to off-white tablets
Molecular Formula Lamivudine (C8H11N3O3S) Tenofovir Disoproxil Fumarate (C19H30N5O10P·C4H4O4)
Salt Composition Lamivudine Tenofovir Disoproxil Fumarate
Medicine Type Antiretroviral
Grade Pharmaceutical Grade
Storage Store below 30°C protect from light and moisture
Assay Not less than 98% purity for both active ingredients
Click to view more
Share Your Product:

Request To Call Back Send Inquiry

Lamivudine And Tenofovir Disoproxil Fumarate Tablets Product Specifications

Appearance White to off-white tablets
Molecular Formula Lamivudine (C8H11N3O3S) Tenofovir Disoproxil Fumarate (C19H30N5O10P·C4H4O4)
Medicine Type Antiretroviral
Salt Composition Lamivudine Tenofovir Disoproxil Fumarate
Grade Pharmaceutical Grade
Storage Store below 30°C protect from light and moisture
CAS No 134678-17-4 (Lamivudine) 202138-50-9 (Tenofovir Disoproxil Fumarate)
Assay Not less than 98% purity for both active ingredients
Expiration Date 24 months from the date of manufacture
Pacakaging (Quantity Per Box) 30 tablets per box
Usage Taken orally as prescribed by a healthcare professional
Dosage Form Tablets
Origin of Medicine Synthetic
Indication Used for the treatment of HIV-1 infection in adults and adolescents
Dosage Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg per tablet

Other Products in 'HIV Medicine' category

Dolutegravir Emtricitabine And Tenofovir Alafenamide Tablet Grade : Pharmaceutical Grade Salt Composition : Dolutegravir sodium Emtricitabine Tenofovir Alafenamide Medicine Type : Antiretroviral Molecular Formula : C20H19F2N3O5 C8H10FN3O3S C21H29N6O5P Appearance : Filmcoated tablet Dosage : Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg Indication : Treatment of HIV1 infection Origin of Medicine : Synthetic Dosage Form : Tablet Pacakaging (Quantity Per Box) : 30 tablets per box Usage : Used in combination as part of antiretroviral therapy for HIV infections Expiration Date : 2 years from date of manufacture Assay : Greater than 99% purity CAS No : 1051375166 1434910920 379270378 Storage : Store below 30°C in a dry place protected from light

Send Inquiry

Sofosbuvir 400 Mg Velpatasvir 100mg Tablets Grade : Pharmaceutical Grade Salt Composition : Sofosbuvir + Velpatasvir Medicine Type : Antiviral Molecular Formula : C22H29FN3O9P (Sofosbuvir) C49H54F2N8O8 (Velpatasvir) Appearance : Filmcoated tablets Dosage : Sofosbuvir 400 mg + Velpatasvir 100 mg Indication : Treatment of chronic Hepatitis C infection Origin of Medicine : Synthetic Dosage Form : Tablet Pacakaging (Quantity Per Box) : 28 Tablets Usage : To inhibit viral replication and cure Hepatitis C infection Expiration Date : 24 months from the date of manufacture Assay : Sofosbuvir Not Less Than 98% Velpatasvir Not Less Than 98% CAS No : 1190307880 (Sofosbuvir) 1377049847 (Velpatasvir) Storage : Store below 30°C protect from moisture

Send Inquiry

Viraday Tablets Cipla Grade : Pharmaceutical Grade Salt Composition : Efavirenz Emtricitabine Tenofovir disoproxil fumarate Medicine Type : Antiviral Molecular Formula : C14H9ClF3NO2 (Efavirenz) C8H10FN3O3S (Emtricitabine) C9H14N5O4P (Tenofovir) Appearance : Coated ovalshaped tablet Dosage : Once daily or as prescribed by a healthcare professional Indication : Treatment of HIV infection Origin of Medicine : India Dosage Form : Tablet Pacakaging (Quantity Per Box) : 30 tablets per box Usage : Prescribed for the management of HIV1 infection in adults and adolescents above 12 years of age Expiration Date : 2 years from the date of manufacture Assay : Efavirenz 600 mg + Emtricitabine 200 mg + Tenofovir disoproxil fumarate 300 mg CAS No : 202138509 (Efavirenz) 192725170 (Emtricitabine) 197922422 (Tenofovir disoproxil fumarate) Storage : Store below 30°C protect from moisture and light

Send Inquiry

Darunavir Tablets 800 Mg Grade : Pharmaceutical Grade Salt Composition : Darunavir Ethanolate Medicine Type : Antiretroviral Molecular Formula : C27H37N3O7S Appearance : White to offwhite solid tablet Dosage : 800 mg per tablet Indication : HIV1 infection treatment Origin of Medicine : Synthetic Dosage Form : Tablet Pacakaging (Quantity Per Box) : 30 tablets per box Usage : Oral administration for the treatment of HIV1 infection in combination with other antiretroviral agents Expiration Date : 24 months from the date of manufacture Assay : Not less than 98.5% CAS No : 206361991 Storage : Store below 30°C protected from light and moisture

Send Inquiry

SEND INQUIRY CALL ME FREE